• Cytokinetics President and CEO Robert I. Blum reported stock sales tied to an option exercise on July 13, 2026.
• Disposed of 7,500 shares at USD 82.02.
• Exercised options for 7,490 shares at USD 10.6.
• Directly held 377,820 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000077), on July 14, 2026, and is solely responsible for the information contained therein.